| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $449K | +3.0% |
| SG&A Expense | $163K | -48.7% |
| Net Income | -$1.9M | +18.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Current Assets | $27K | -68.2% |
| Total Assets | $463K | +3.7% |
| Current Liabilities | $42K | -55.5% |
| Stockholders' Equity | $421K | +19.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$805K | +9.6% |
| Investing Cash Flow | -$132K | -45.1% |
| Financing Cash Flow | $905K | +7.1% |